Catherine Cohet, Brigitte Cheuvart, Leentje Moerman, Dan Bi, Adrian Caplanusi, Mallesh Kariyappa, . . . Sanjay Gandhi. (2021). A phase III randomized, open-label, non-inferiority clinical trial comparing liquid and lyophilized formulations of oral live attenuated human rotavirus vaccine (HRV) in Indian infants. Taylor & Francis Group.
Chicago Style (17th ed.) CitationCatherine Cohet, et al. A Phase III Randomized, Open-label, Non-inferiority Clinical Trial Comparing Liquid and Lyophilized Formulations of Oral Live Attenuated Human Rotavirus Vaccine (HRV) in Indian Infants. Taylor & Francis Group, 2021.
MLA (9th ed.) CitationCatherine Cohet, et al. A Phase III Randomized, Open-label, Non-inferiority Clinical Trial Comparing Liquid and Lyophilized Formulations of Oral Live Attenuated Human Rotavirus Vaccine (HRV) in Indian Infants. Taylor & Francis Group, 2021.